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Toxigenic strains of Clostridium difﬁcile may be disseminating. Here we  prospectively
screened  patients with nosocomial diarrhoea in two hospitals in Brazil. To identify C. difﬁcile
polymerase  chain reaction ribotypes 027/078 strains, we used high resolution melting and
multiplex polymerase chain reaction. Among 116 screened patients, 11 were positive for C.
difﬁcile. The polymerase chain reaction ribotypes 027/078 strains were not identiﬁed in this
study.Multiplex-PCR
Clostridium difﬁcile
HRM
Toxin  gene proﬁling
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Clostridium difﬁcile is the main infectious agent of nosocomial
diarrhoea, which may  result in signiﬁcant morbimortality.1
Recently, toxigenic strains of C. difﬁcile have emerged, some-
times  causing outbreaks.2 Most of these infections are caused
by  the polymerase chain reaction (PCR) ribotypes 027 and 078
also referred to as BI/NAP1 and BK/NAP7, respectively. Very
limited  data are available on the frequency of toxigenic strains
in  Latin America. A study from Costa Rica revealed that 54%
(20/37)  isolates of C. difﬁcile were identiﬁed as C. difﬁcile PCR
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1413-8670/© 2014 Elsevier Editora Ltda. Este é um artigo Open Access sob a licençaribotype 027.3 No other study has documented toxigenic C.
difﬁcile  strains in Latin America. Here we investigated whether
strains  027/078 were present in cases of nosocomial diarrhoea
in  a cohort study in Brazil.
This  was a multicenter prospective observational study,
conducted in two hospitals in Porto Alegre, Brazil.4 Hospi-
tal  1 is a 65-bed transplant hospital; Hospital 2 is a 800-bed
tertiary hospital, including 40 intensive care unit beds. Inpa-
tient  adults (>18 years-old) passing ≥3 liquid stools over ae Misericordia de Porto Alegre, Av Independência 155, 8◦ andar,
a.edu.br (A.C. Pasqualotto).
24  h period were included. Participation in the study was
conditioned to signing an informed consent (ISCMPA Ethics
Committee  approval – 304/010).
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Fig. 1 – Typing of C. difﬁcile using multiplex conventional polymerase chain reaction (PCR) on 11 clinical isolates. Lane 1: no
template control; Lane 2: C. difﬁcile 027 (positive control strain); Lane 3, C. difﬁcile 078 (positive control strain); Lane 15:
100 bp DNA ladder; Additional lanes: clinical samples numbered according to their identiﬁcation in the study; The position
of  the different C. difﬁcile gene toxins (i.e., tcdA, tcdB, cdtA, cdtB, tcdC) as well as 16S rDNA, internal control are marked on
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Faecal samples were inoculated on C. difﬁcile agar (CLO)
elective medium (bioMérieux, France) and incubated anaer-
bically  for 48 h at 37 ◦C. DNA was  extracted from bacterial
olonies using QIAamp DNA Stool Mini Kit, Qiagen. Molecu-
ar  characterization of strains was  performed by conventional
ultiplex PCR (mPCR) test, as previously published.5 mPCRs
ere  adjusted to a ﬁnal volume of 25 L, containing the follow-
ng:  2.5 L of 10× PCR buffer (200 mM Tris-HCl [pH 8.4], 500 mM
Cl),  2 mM MgCl2, 260 mM of each deoxyribonucleotide, 1.5 U
f Platinum Taq DNA Polymerase (Invitrogen), primers (same
rimers  and concentrations as used in Persson et al.6), and
 L of genomic DNA. Positive controls used in this reaction
ere  obtained from the Statens Serum Institut – Denmark (C.
ifﬁcile  027 – F62 and C. difﬁcile 078 – M16). Milli-Q® water was
sed  as a negative control. All mPCRs were  performed in a Ver-
ti  thermal cycler (Life Technologies). Cycling conditions were:
0  min  at 94 ◦C, followed by 35 cycles of 50 s at 94 ◦C, 40 s at
4 ◦C, 50 s at 72 ◦C, and a ﬁnal extension of 3 min  at 72 ◦C.
Amplicons  sizes were  checked by 3.0% (w/v) agarose
el-electrophoresis stained with ethidium bromide. The
mplicons  tcdC (126 and 144 bp, resulting from internal dele-
ions  of sizes 39 and 18 bp, respectively), as well as the
mplicons 16S rDNA, tcdA, tcdB and tcdA/tcdB, were used as
tandards  in each reaction.
Besides  the molecular characterization of C. difﬁcile by
PCR,  we  optimized a qPCR using high resolution melting
HRM)  analysis, adapting the protocol described by Grando
t  al.7 Type-it HRM PCR (Qiagen) was  used to prepare the mix.
he  PCR mixtures were  optimized for a volume of 50 L, con-
aining  25 L of 2× HRM PCR Master Mix  (Qiagen), 0.5 M of
oth  forward and reverse primers, 15 L Milli-Q water and
 L of the genomic template DNA (or Milli-Q water as no
emplate  control). Thermocycling conditions and curve nor-
alization  were  performed according the protocol proposed
y  Grando et al.7 After normalizing the curves, results were
nterpreted by subtracting the melting-curve shapes gener-
ted  by the standard (C. difﬁcile 027 reference strain) from the
urves  generated for the other isolates and standards.From the 116 patients included in the study, 11 had positive
ultures for C. difﬁcile, and these were  evaluated for the pres-
nce  of hypervirulent characteristics. Among these, 10 clinicalstrains  were non-toxigenic while one strain harboured tcdA
and  tcdB. When compared to controls, none of the isolates had
toxin  gene proﬁles similar to ribotypes 027/078 (Fig. 1). These
results  were conﬁrmed by HRM, in which none of the isolates
showed  peaks compatible with PCR ribotypes 027/078 (Fig. 2).
Molecular  typing of C. difﬁcile is still not widely used in
tertiary  hospitals in Brazil, despite the known emergence of
toxigenic  C. difﬁcile strains. Proper typing of C. difﬁcile may  be of
relevance  for infection control purposes. Several methods for
the differentiation of C. difﬁcile isolates are currently available,
including PCR-ribotyping, restriction endonuclease analysis,
and  pulsed-ﬁeld gel electrophoresis.8 Performing more  than
one  typing method could potentially increase the discrim-
inatory power of a single typing method, even though few
laboratories follow this practice.2 The mPCR is a rapid and spe-
ciﬁc  method for screening toxin genes of C. difﬁcile. This is a
simple  and relatively cheap method that allows for the pre-
sumptive  typing of C. difﬁcile strains.6 On the other hand, HRM
analysis  of PCR products can identify the different genotypic
variations among different bacteria. Despite being a more
expensive method, HRM offers quicker results and has demon-
strated  a discriminatory power as high as 0.928.7
In this study, no patient was  found to be infected by C.
difﬁcile  PCR ribotype 027/078 strains. Similar ﬁndings were
described  in a previous study in Brazil, in which ribotyping
was  performed.9 So far, these strains have not been docu-
mented  in Brazil. However, considering that molecular typing
technologies and anaerobic cultures are still limited in the
country,  underdetection of C. difﬁcile ribotypes 027/078 strains
is  also a possibility.9 Even though PCR ribotype 027/078 strains
were  not detected in this study, our analysis revealed the
presence  of nine different HRM C. difﬁcile proﬁles (data not
shown).
This  study has some limitations. Unfortunately it was  not
possible  to classify the samples that were negative for PCR
ribotype  027/078, according to the nomenclature proposed by
Stubbs et al.10 Also, despite being a prospective multicenter
study, only a small number of isolates tested positive for C.
difﬁcile  (11/116). Increasing sample size could potentially result
in  the identiﬁcation of hypervirulent C. difﬁcile strains. As all
isolates  showed different peaks in comparison to controls, the
674  b r a z j i n f e c t d i s . 2 0 1 4;1  8(6):672–674
A B
C D
C. difficile 027
C. difficile 027
C. difficile 027
C. difficile 078
C. difficile 078
Samples 4, 5, 8
Samples 4, 5, 8
C. difficile 078
Fig. 2 – (A) Melt peak curves on the HRM analysis for the two positive control strains (C. difﬁcile 027/078) and the 11 clinical
isolates included in this study. (B) Two positive control strains as well as clinical isolates 4, 5 and 8. (C) Difference plotting of
the HMR  curves for C. difﬁcile 078 positive control strain, in addition to 11 clinical isolates; C. difﬁcile 027 is used as reference
isola
r
10. Stubbs SLJ, Brazier JS, O’Neill GL, Duerden BI. PCR targeted toin the graphic. (D) Two control strains (027/078) and clinical 
discriminatory power of the methods for the detection of C.
difﬁcile  027/078 could not be determined.
In conclusion, this study did not detect the presence of C.
difﬁcile  027/078 hypervirulent strains in a prospective cohort of
patients  with nosocomial diarrhoea in Brazil. The importance
of  implementing molecular typing methods for C. difﬁcile in a
continental country such as Brazil deserves additional atten-
tion.
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